摘要
肝内胆管癌(ICC)是原发性肝癌的一种类型,占总病例的10%~15%,发病率和死亡率在全球范围内呈显著上升趋势,尤其是在亚洲国家。目前,根治性切除术是唯一可能治愈ICC的方式,然而术后复发率高,预后较肝细胞癌差。因此,急需进一步研究ICC的发生和发展机制,寻找更有效的治疗手段。一些流行病学数据显示,慢性HBV感染是ICC发生的最主要易感因素之一,然而人们对相关致癌作用知之甚少。本综述总结了二者之间的流行病学证据,简要概述了HBV相关ICC发生发展的机制,以期能有助于更好地了解HBV在ICC发生和发展中的作用。
Intrahepatic cholangiocarcinoma(ICC)is a type of primary liver cancer that accounts for about 10%—15%of the total cases,and its incidence and mortality rates tend to increase significantly around the world,especially in Asian countries.At present,radical liver resection is the only possible cure for ICC,but with a fairly high postoperative recurrence rate and a poorer prognosis than hepatocellular carcinoma.Therefore,it is urgently needed to further investigate the mechanisms of the development and progression of ICC and search for more effective treatment methods.Some epidemiological data suggest that chronic hepatitis B virus infection is one of the most important predisposing factors for ICC,yet little is known about its oncogenic effects.This article summarizes the epidemiological evidence that links the two diseases and briefly elaborates on the mechanisms of the development and progression of HBV-associated ICC,so as to help to gain a better understanding of the role of HBV in the development and progression of ICC.
作者
田奇玉
余建
黄罡
TIAN Qiyu;YU Jian;HUANG Gang(Graduate School of Navy Medical University,Shanghai 200433,China;Department of General Surgery,Eastern Hepatobiliary Surgery Hospital,Navy Medical University,Shanghai 200438,China)
出处
《临床肝胆病杂志》
CAS
北大核心
2024年第4期797-803,共7页
Journal of Clinical Hepatology
基金
国家自然科学基金(82002458)。
作者简介
通信作者:黄罡,squaror@163.com(ORCID:0009-0000-4574-4079)。
